Prevention is key in avoiding gray baby syndrome. This involves the cautious use of chloramphenicol in neonates and infants, only when absolutely necessary and when no safer alternatives are available. Guidelines suggest avoiding its use entirely in premature infants. If used, careful monitoring of drug levels and adjusting doses accordingly can mitigate the risk of toxicity.
